Cover Image
市場調查報告書

經皮疼痛管理:產品·市場與預測·機會

Transdermal Pain Management to 2020- Products, Markets, Opportunities and Forecasts

出版商 Greystone Research Associates 商品編碼 138804
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
經皮疼痛管理:產品·市場與預測·機會 Transdermal Pain Management to 2020- Products, Markets, Opportunities and Forecasts
出版日期: 2014年12月01日 內容資訊: 英文
簡介

本報告提供經皮止痛藥經濟性方面,技術,可治療條件,商業性的可能性等詳細分析,提供促進市場成長的要素和今後預測,再加上主要企業簡介,為您概述為以下內容。

摘要整理

調查範圍·定義

疼痛管理市場商機

  • 疼痛管理指南的演進
  • 疼痛管理治療的地區性要素
  • 需求推動因素
  • 競爭情形
  • 成長阻礙因素

經皮藥物遞輸的動態

  • 經皮止痛貼片
    • 止痛貼片的技術和架構
    • 經皮吸收貼片的生產與包裝
    • 貼片經濟性方面
    • 被動式和主動式的給藥系統
  • 經皮止痛凝膠
    • 經皮處方
    • 智慧財產權和專利技術
    • 局部凝膠的規定

經皮止痛藥的評估和市場預測

  • FDA所認証通過的經皮止痛藥
    • 麻醉劑
    • 非類固醇系抗發炎劑
    • 局部麻醉
  • FDA未認証通過的經皮止痛藥
    • 麻醉劑
    • 非類固醇系抗發炎劑
    • 局部麻醉
  • 處於開發階段的經皮止痛藥
    • 麻醉劑
    • 非類固醇系抗發炎劑
    • 其他的藥物類別

經皮疼痛管理市場要素

  • 各國的法規
  • 品質和可靠性
  • 適應症處方指南和FDA Off-Label Prescribing
  • 管理護理和Payor Initiatives
  • 皮膚貼片的收益模式

市場預測

  • 不同地區的預測
  • 各類藥物的預測
  • 各傳送形態的預測
  • 市場佔有率資料

企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: TPX602R

‘Transdermal Pain Management to 2020: Products, Markets, Opportunities and Forecasts’ is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the pain management drug sector.

The study is designed to provide drug company decision makers, pain product managers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, treatable conditions, and commercial opportunities for transdermal pain management. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Drug Products and Candidates for a Growing Clinical Need

As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing a higher level of emphasis on pain management as a quality-of-life issue for patients and their families. Responding to this trend, drug developers are increasingly turning to transdermal formulations of pain management drugs. Because it has the potential to improve drug therapy compliance, transdermal delivery addresses a key healthcare issue - one that is particularly problematic in aging populations and developing economies. Currently approved transdermal pain products include narcotics, NSAIDs, and topical anesthetics. These patches and gels will encounter competition from development-stage transdermal formulations for a number of pain medications presently being marketed in oral or parenteral form. Several of these development programs involve international partnerships designed to take advantage of perceived opportunities in regional markets.

What You Will Learn

  • What drugs indicated for managing pain are supplied as transdermal formulations, what are the formulation and product specifics, and who markets them
  • Who are the branded transdermal pain management product suppliers, their business models, and their capabilities
  • What are the major factors driving transdermal pain product demand
  • How important are drug developer-formulator-device manufacturer relationships and what are the key alliances in the industry
  • What are the essential design factors, material selection issues, technologies and market development issues for transdermal pain management products
  • What are the competing pain management product segments and what is their market share
  • What are the significant economic, technology, and regulatory factors affecting the market for transdermal pain management

Table of Contents

Executive Summary

  • Scope and Definitions
  • The Current Pain Management Picture
  • Unmet Needs in Pain Management
  • The Opportunity for Transdermal Delivery of Pain Drugs

The Pain Management Market Opportunity

  • Evolution in Pain Management Guidelines
  • Regional Factors in Pain Management Practice
  • Pain Management Demand Drivers
  • Competitive Landscape
  • Factors Limiting Growth

Transdermal Drug Delivery Dynamics

  • Transdermal Pain Management Patches
    • Pain Patch Technology & Architectures
    • Transdermal Patch Manufacturing and Packaging
    • Patch Economics
    • Passive vs Active Delivery Systems
  • Transdermal Pain Management Gels
    • Transdermal Formulations
    • IP and Proprietary Technology
    • Limitations of Topical Gels

Transdermal Pain Management Product Assessments and Market Prospects

  • FDA Approved Transdermal Pain Management Products
    • Narcotic
    • NSAIDs
    • Local Anesthetic
  • Non-FDA Approved Commercial Transdermal Pain Management Products
    • Narcotic
    • NSAIDs
    • Local Anesthetic
  • Development-Stage Transdermal Pain Management Products
    • Narcotic
    • NSAID
    • Other Drug Classes

Transdermal Pain Management Market Factors

  • Regional Regulations
  • Quality and Reliability
  • Indications Prescribing Guidelines and Off-Label Prescribing
  • Managed Care and Payor Initiatives
  • Skin Patch Revenue Models

Market Forecasts

  • Forecasts by Region
  • Forecasts by Drug Class
  • Forecasts by Delivery Form Factor
  • Market Share Data

Company Profiles

Back to Top